Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
|
N Engl J Med
|
2012
|
27.84
|
2
|
The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
|
AIDS
|
2005
|
4.48
|
3
|
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
|
Lancet
|
2010
|
4.23
|
4
|
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2007
|
3.78
|
5
|
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
|
PLoS One
|
2009
|
3.66
|
6
|
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
|
PLoS One
|
2011
|
3.27
|
7
|
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
|
Clin Infect Dis
|
2005
|
3.00
|
8
|
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
|
PLoS Med
|
2013
|
2.44
|
9
|
The etiology of urinary tract infection: traditional and emerging pathogens.
|
Dis Mon
|
2003
|
2.39
|
10
|
HIV counseling and testing practices at an urban hospital in Kampala, Uganda.
|
AIDS Behav
|
2006
|
1.83
|
11
|
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.
|
BMC Psychiatry
|
2010
|
1.73
|
12
|
Linkage to HIV care and survival following inpatient HIV counseling and testing.
|
AIDS Behav
|
2011
|
1.66
|
13
|
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.
|
Clin Infect Dis
|
2009
|
1.64
|
14
|
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics.
|
Nature
|
2006
|
1.48
|
15
|
Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples.
|
AIDS
|
2010
|
1.37
|
16
|
Pattern of neuropsychological performance among HIV positive patients in Uganda.
|
BMC Neurol
|
2007
|
1.35
|
17
|
Resurrecting the triple threat: academic social responsibility in the context of global health research.
|
Clin Infect Dis
|
2009
|
1.29
|
18
|
The academic alliance for AIDS care and prevention in Africa.
|
Acad Med
|
2008
|
1.27
|
19
|
Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda.
|
J Acquir Immune Defic Syndr
|
2006
|
1.25
|
20
|
The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda.
|
Afr Health Sci
|
2008
|
1.25
|
21
|
Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics.
|
Nature
|
2006
|
1.13
|
22
|
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.
|
PLoS One
|
2009
|
1.11
|
23
|
Meningitis caused by Streptococcus suis serotype 14, North America.
|
Emerg Infect Dis
|
2009
|
1.11
|
24
|
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
|
Afr Health Sci
|
2004
|
1.10
|
25
|
The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes.
|
Int J Infect Dis
|
2007
|
1.10
|
26
|
Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.
|
J Int Assoc Physicians AIDS Care (Chic)
|
2008
|
1.07
|
27
|
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
|
J Acquir Immune Defic Syndr
|
2016
|
1.02
|
28
|
Advances in clinical education: a model for infectious disease training for mid-level practitioners in Uganda.
|
Int J Infect Dis
|
2012
|
1.02
|
29
|
Measuring the outcomes of a comprehensive HIV care course: pilot test at the Infectious Diseases Institute, Kampala, Uganda.
|
J Acquir Immune Defic Syndr
|
2006
|
1.01
|
30
|
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.
|
J Acquir Immune Defic Syndr
|
2014
|
0.98
|
31
|
Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.
|
AIDS
|
2014
|
0.97
|
32
|
Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
|
AIDS
|
2014
|
0.96
|
33
|
Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.
|
Antimicrob Agents Chemother
|
2011
|
0.96
|
34
|
The liver in HIV in Africa.
|
Antivir Ther
|
2005
|
0.94
|
35
|
Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans.
|
J Infect Dis
|
2013
|
0.91
|
36
|
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.
|
Neurology
|
2012
|
0.91
|
37
|
Treatment of HIV/AIDS: do the dilemmas only increase?
|
JAMA
|
2004
|
0.89
|
38
|
Challenges in diagnosis, treatment and follow-up of patients presenting with central nervous system infections in a resource-limited setting.
|
Mcgill J Med
|
2006
|
0.89
|
39
|
Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic.
|
J Int AIDS Soc
|
2009
|
0.88
|
40
|
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2008
|
0.88
|
41
|
Diagnostic challenges of sexually transmitted infections in resource-limited settings.
|
Future Microbiol
|
2009
|
0.85
|
42
|
Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting.
|
Afr Health Sci
|
2007
|
0.83
|
43
|
First report of Actinobaculum schaalii urinary tract infection in North America.
|
Diagn Microbiol Infect Dis
|
2010
|
0.82
|
44
|
The prevalence and causes of visual loss among HIV-infected individuals in Uganda.
|
J Acquir Immune Defic Syndr
|
2010
|
0.82
|
45
|
Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381).
|
AIDS
|
2002
|
0.81
|
46
|
Disease diagnosis in primary care in Uganda.
|
BMC Fam Pract
|
2014
|
0.81
|
47
|
A renal aspergilloma--an unusual presentation of aspergillosis in an HIV patient.
|
Afr Health Sci
|
2005
|
0.80
|
48
|
Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa.
|
AIDS
|
2016
|
0.80
|
49
|
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.
|
J Acquir Immune Defic Syndr
|
2016
|
0.80
|
50
|
Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
51
|
Correction: Improving Facility Performance in Infectious Disease Care in Uganda: A Mixed Design Study with Pre/Post and Cluster Randomized Trial Components.
|
PLoS One
|
2016
|
0.75
|
52
|
Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans.
|
J Acquir Immune Defic Syndr
|
2014
|
0.75
|
53
|
Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
54
|
Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
55
|
The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion.
|
AIDS
|
2017
|
0.75
|